Transferrin receptor 1 mRNA is downregulated in placenta of hepcidin transgenic embryos

FEBS Lett. 2004 Sep 10;574(1-3):187-91. doi: 10.1016/j.febslet.2004.08.010.

Abstract

We have previously shown that hepcidin transgenic embryos are severely anemic and die around birth. Here, we report that embryonic hepcidin transgene expression decreases transferrin receptor 1 (TfR1) mRNA level in placenta, as shown by cDNA microarray analysis and quantitative RT-PCR, by a mechanism which is independent of placenta iron content and iron responsive element/iron regulatory protein (IRE/IRP) activity. On the contrary, iron injections into pregnant mothers result in increased placenta iron and ferritin content, and reduced IRE binding activity of IRP1 leading to decreased TfR1 mRNA level. Taken together, these results suggest that hepcidin action on placenta is mostly through transcriptional downregulation of the iron uptake machinery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimicrobial Cationic Peptides / genetics
  • Antimicrobial Cationic Peptides / physiology*
  • Base Sequence
  • DNA Primers
  • Down-Regulation*
  • Embryo, Mammalian / metabolism*
  • Female
  • Hepcidins
  • Iron / metabolism
  • Male
  • Mice
  • Mice, Transgenic
  • Placenta / metabolism*
  • RNA, Messenger / genetics*
  • Receptors, Transferrin / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Antimicrobial Cationic Peptides
  • DNA Primers
  • Hamp protein, mouse
  • Hepcidins
  • RNA, Messenger
  • Receptors, Transferrin
  • Iron